AMERICAN CENTURY COMPANIES INC

Position in DSGN — Design Therapeutics, Inc.

CIK 748054 KANSAS CITY, MO

Position in DSGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$698,388

+$156,243 QoQ

Shares Held

65,638

+13.6% QoQ

Ownership

0.105%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

AMERICAN CENTURY COMPANIES INC holds $3,844,388,733 across 170 Biotechnology names. DSGN ranks #102 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,802,363	$596,347,845
2	REGN	Regeneron Pharmaceuticals, Inc.	562,097	$434,298,626
3	VRTX	Vertex Pharmaceuticals Inc / Ma	813,285	$363,164,283
4	ASND	Ascendis Pharma A/S	1,397,119	$319,563,028
5	INSM	INSMED Inc	925,799	$151,386,652
6	ARGX	Argenx SE	173,700	$126,844,425
7	IONS	Ionis Pharmaceuticals Inc	1,663,803	$124,934,967
8	CPRX	Catalyst Pharmaceuticals, Inc.	4,138,416	$102,467,180

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$698,388	65,638	+13.6%	Shares	Defined	2026-05-15
2025-12-31	$542,145	57,798	+13.7%	Shares	Defined	2026-02-13
2025-09-30	$382,915	50,852	+9.6%	Shares	Defined	2025-11-12
2025-06-30	$156,317	46,385	+4.4%	Shares	Defined	2025-08-12
2025-03-31	$171,441	44,415	+13.5%	Shares	Defined	2025-05-13
2024-12-31	$241,339	39,115	+19.9%	Shares	Defined	2025-02-11
2024-09-30	$175,570	32,634	+53.0%	Shares	Defined	2024-11-12
2024-06-30	$71,465	21,333	—	Shares	Defined	2024-08-07
No filing history on record for this holder in this stock.